Post-doctoral research associate, The University of Sheffield Medical School
BIOGRAPHY
FEB 26, 2019 11:00 AM PST
Share
Osteosarcoma research
Abstract
DATE: February 26, 2019
TIME: 11:00am PST, 2:00pm EST
Osteosarcoma is the most common type of primary bone cancer affecting adolescents and children attributed to rapid bone growth and turnover with a peak incidence at 18 years old. it is a rare incurable and often fatal disease. The current osteosarcoma treatments include standard chemotherapy, limb salvage surgery or amputation. The 5-year relative survival rate is 70% for localized forms, however, metastasis is present in about one fifth to one quarter of patients at diagnosis, which then contributes to a 5-year survival rate of around 20%. The survival statistics have remained constant with no advances in treatment options for decades highlighting the need for new therapeutic options.
Learning Objectives:
- An overview of osteosarcoma disease
- An overview of osteosarcoma research & preclinical models
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
MAY 11, 2021
10:00 AM PDT
C.E. CREDITS
MAY 11, 2021
10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021
7:00 AM PDT
C.E. CREDITS
SEP 14, 2021
7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021
7:00 AM PDT
C.E. CREDITS
JUN 09, 2021
7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021
8:00 AM PDT
C.E. CREDITS
JUL 15, 2021
8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
JUN 03, 2021
12:00 PM CST
JUN 03, 2021
12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
APR 01, 2021
8:00 AM PDT
C.E. CREDITS
APR 01, 2021
8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
Specialty
Cancer Research
Molecular Biology
Cell Biology
Genetics
Immunology
Clinical Research
Medicine
Cancer Diagnostics
Cancer Therapeutics
Laboratory Testing
Biotechnology
Biochemistry
Clinical Diagnostics
Diagnostics
Drug Discovery
Geography
North America61%
Asia15%
Europe14%
Africa5%
South America4%
Registration Source
Email Promotions41%
Website Visitors39%
WAVE Newsletter Promotion9%
Social Media Promotions2%
Website Banners1%
Trending Newsletter Promotion1%
Other5%
Job Title
Student17%
Medical Laboratory Technician16%
Research Scientist11%
Educator/Faculty11%
Medical Doctor/Specialist8%
Executive7%
Clinical Laboratory Scientist6%
Facility/Department Manager6%
Lab Management5%
Scientist5%
Veterinarian2%
Marketing/Sales1%
Post Doc1%
Biologist1%
Chemist1%
QC/QA1%
Consultant1%
Pathologist1%
Organization
Academic Institution25%
Hospital15%
Clinical Laboratory11%
Research Institute7%
Medical Center6%
Biotech Company6%
Medical School4%
Government4%
Pharmaceutical Company3%
Ambulatory Care2%
Consultant1%
Non-Profit Organization1%
Independent Laboratories1%
Life Science Company1%
Other3%
Loading Comments...
Finish Registering
-
SEP 22, 2021Cell Biology 2021 -
SEP 29, 2021CRISPR 2021
-
OCT 04, 20218th Annual Conference: SBI2 High Content
-
OCT 05, 2021Lab Compliance Connect
-
OCT 06, 2021Cancer Research & Oncology 2021
- See More
-
SEP 19, 2021
- See More
